Renowned pharmacologist Professor Tommy Cheng shares insights on invention of anti-cancer Chinese medicine

1 April 2010


Renowned pharmacologist Professor Yung-chi Tommy Cheng was invited to visit the School of Chinese Medicine and deliver a seminar on the topic "Exploration of PHY906, a TCM Formula as Adjuvant Therapy for Cancer Patients Undergoing Chemotherapy" on 29 March.

The seminar was well-received with over 100 participants from Hospital Authority, Hong Kong Anti-cancer Society Jockey Club Cancer Rehabilitation Centre, Chinese medicine industry, academic and research staff and postgraduate students of the School.

In the seminar, Professor Cheng shared insights and experiences with participants on his invention HY906?/st1:chmetcnv>, candidate for the approved traditional Chinese medicine anti-cancer adjuvant therapy of U.S. Food and Drug Administration. There was a fruitful academic exchange on new perspectives of traditional Chinese medicine research in the international arena.

Professor Cheng is the Henry Bronson Professor of Pharmacology, and Professor of Medicine and Director of the Developmental Therapeutics Program of the Yale Comprehensive Cancer Center at Yale University. He is also Chairman of the Consortium for Globalisation of Chinese Medicine.

Professor Cheng is a leader in cancer and viral pharmacology. Five chemicals have been discovered in his laboratory that are under clinical trials for the treatment of cancer, hepatitis B and human immunodeficiency virus.